Skip to main content

We've saved some files called cookies on your device. These cookies are:

  • essential for the site to work
  • to help improve our website by collecting and reporting information on how you use it

We would also like to save some cookies to help tailor communications.

BETA
You're viewing an updated version of this service - your feedback will help us to improve it.

Contract Notice

Cell Therapy Catapult Process Development Partners.

  • First published: 24 December 2013
  • Last modified: 24 December 2013
  • Version: N/A
  • This file may not be fully accessible.

  •  

Information icon

The buyer is not using this website to administer the notice.

To record your interest or obtain additional information or documents please find instructions within the Full Notice Text. (NOTE: Contract Award Notices and Prior Information Notices do not normally require a response)

Information icon
You are viewing an expired notice.

Contents

Summary

OCID:
Published by:
Cell & Gene Therapy Catapult
Authority ID:
AA58950
Publication date:
24 December 2013
Deadline date:
20 January 2014
Notice type:
Contract Notice
Has documents:
No
Has SPD:
No
Has Carbon Reduction Plan:
N/A

Abstract

The Cell Therapy Catapult has recognised the need to engage with established Process Development Partners to leverage existing expertise across the Cell Therapy industry in its pursuit of the rapid development, delivery and commercialisation of cell therapies.

Whilst the Cell Therapy Catapult has a vast array of internal capability and process development expertise, it recognises the need to engage with specialist process development providers and industry experts in order to maximise the product development possibilities across the industry.

The Cell Therapy Catapult are engaged in numerous process development projects with an array of diverse products, and therefore they wish to engage in a framework agreement with several suppliers covering a wide range of skills and capabilities in order that these can be leveraged when required.

Full notice text

CONTRACT NOTICE – OFFICIAL JOURNAL

Section I: Contracting Authority

I.1)

Name, Address and Contact Point(s)


Cell Therapy Catapult

Guy's Tower, Great Maze Pond

London

SE1 9RT

UK

Jodie Hill


ojeu@ct.catapult.org.uk


http://catapult.org.uk/celltherapy


Checked box
Unchecked box
Checked box
Unchecked box
Checked box
Unchecked box

I.2)

Type of contracting Authority and Main Activity or Activities

Checked box
Private Company Limited by Guarantee
Unchecked box
Unchecked box
Unchecked box
Unchecked box
Unchecked box
Unchecked box
Unchecked box
Unchecked box
Unchecked box
Unchecked box
Checked box
Cell Therapies
No

Section II: Object of the Contract

II.1)

Description

II.1.1)

Title attributed to the contract by the contracting authority

Cell Therapy Catapult Process Development Partners.

II.1.2(a))

Type of works contract

II.1.2(b))

Type of supplies contract

II.1.2(c))

Type of service contract

8

II.1.2)

Main site or location of works, place of delivery or performance

London.



II.1.3)

This notice involves

Unchecked box
Unchecked box
Checked box

II.1.4)

Information on framework agreement (if applicable)

Unchecked box
Checked box

Number of participants to the framework agreement envisaged

6

Duration of the framework agreement

4

Justification for a framework agreement the duration of which exceeds four years

Estimated total value of purchases for the entire duration of the framework agreement

5 000 000GBP

Frequency and value of the contracts to be awarded

II.1.5)

Short description of the contract or purchase(s)

The Cell Therapy Catapult has recognised the need to engage with established Process Development Partners to leverage existing expertise across the Cell Therapy industry in its pursuit of the rapid development, delivery and commercialisation of cell therapies.

Whilst the Cell Therapy Catapult has a vast array of internal capability and process development expertise, it recognises the need to engage with specialist process development providers and industry experts in order to maximise the product development possibilities across the industry.

The Cell Therapy Catapult are engaged in numerous process development projects with an array of diverse products, and therefore they wish to engage in a framework agreement with several suppliers covering a wide range of skills and capabilities in order that these can be leveraged when required.

II.1.6)

Common Procurement Vocabulary (CPV)

71900000
73111000
73120000
73210000
73220000
73300000

II.1.7)

Contract covered by the Government Procurement Agreement (GPA)

Unchecked box

II.1.8)

Division into lots

No

II.1.9)

Will variants be accepted

No

II.2)

Quantity or Scope of the Contract

II.2.1)

Total quantity or scope

The total estimated value of call offs under the framework is 5 000 000 GBP.

5 000 000
GBP

II.2.2)

Options

Provisional timetable for recourse to these options

Number of possible renewals

In the case of renewable supplies or service contracts, estimated time frame for subsequent contracts

II.3)

Duration of the contract or limit for completion

48

Section III: Legal, Economic, Financial and Technical Information

III.1)

Conditions Relating to the Contract

III.1.1)

Deposits and guarantees required

Tenderers may be requested to sign a Parent Company Guarantee, depending on the evaluation of Financial Information.

III.1.2)

Main Terms of financing and payment and/or reference to the relevant provisions

III.1.3)

Legal form to be taken by the grouping of suppliers, contractors or service providers to whom the contract is to be awarded

III.1.4)

Other particular conditions to which the performance of the contract is subject

Any conditions will be detailed in the tender documents.

III.2)

Conditions for Participation

III.2.1)

Personal situation of economic operators, including requirements relating to enrolment on professional or trade registers


Please see the PQQ.

III.2.2)

Economic and financial capacity


Please see the PQQ.



Please see the PQQ.


III.2.3)

Technical capacity


Please see the PQQ.



Please see the PQQ.


III.2.4)

Reserved contracts

Unchecked box
Unchecked box

III.3)

Conditions Specific to Service Contracts

III.3.1)

Is provision of the service reserved to a specific profession?

No

III.3.2)

Will legal entities be required to state the names and professional qualifications of the personnel responsible for the execution of the service?

No

Section IV: Procedure

IV.1)

Type of Procedure


Unchecked box Checked box
Unchecked box Unchecked box
Unchecked box Unchecked box

Justification for the choice of accelerated procedure

IV.1.1)

Have candidates already been selected?

No

IV.1.2)

Limitations on the number of operators who will be invited to tender or to participate

510

Objective criteria for choosing the limited number of candidates

Please see the PQQ.

IV.1.3)

Reduction of the number of operators during the negotiation or dialogue

Unchecked box

IV.2)

Award Criteria

No


Yes

No

IV.2.2)

An electronic auction will be used

No

IV.3 Administrative Information

IV.3.1)

Reference number attributed to the notice by the contracting authority

CON-0035

IV.3.2)

Previous publication(s) concerning the same contract

Unchecked box
Unchecked box


Other previous publications

IV.3.3)

Conditions for obtaining specifications and additional documents



 


IV.3.4)

Time-limit for receipt of tenders or requests to participate

 20-01-2014  13:00

IV.3.5)

Date of dispatch of invitations to tender or to participate to selected candidates


IV.3.6)

Language or languages in which tenders or requests to participate can be drawn up

Checked box    

IV.3.7)

Minimum time frame during which the tenderer must maintain the tender 

IV.3.8)

Conditions for opening tenders





Section VI: Other Information

VI.1)

Indicate whether this procurement is a recurrent one and the Estimated timing for further notices to be published


VI.2)

Does the contract relate to a Project/Programme financed by Community Funds?

No



VI.3)

Additional Information

To express interest and request a copy of the PQQ please email: ojeu@ct.catpult.org.uk. The deadline for completed PQQs is 20.1.2014 at 13:00.

VI.4)

Procedures for appeal

VI.4.1)

Body responsible for appeal procedures










Body responsible for mediation procedures










VI.4.2)

Lodging of appeals

VI.4.3)

Service from which information about the lodging of appeals may be obtained


Cell Therapy Catapult





OJEU@ct.catapult.org.uk



VI.5)

Dispatch date of this Notice

 20-12-2013

Coding

Commodity categories

ID Title Parent category
73300000 Design and execution of research and development Research and development services and related consultancy services
73220000 Development consultancy services Research and development consultancy services
73120000 Experimental development services Research and experimental development services
71900000 Laboratory services Architectural, construction, engineering and inspection services
73210000 Research consultancy services Research and development consultancy services
73111000 Research laboratory services Research services

Delivery locations

ID Description
There are no delivery locations for this notice.

Alert region restrictions

The buyer has restricted the alert for this notice to suppliers based in the following regions.

ID Description
There are no alert restrictions for this notice.

About the buyer

Main contact:
ojeu@ct.catapult.org.uk
Admin contact:
N/a
Technical contact:
N/a
Other contact:
N/a

Further information

Date Details
No further information has been uploaded.

0800 222 9004

Lines are open 8:30am to 5pm Monday to Friday.

Rydym yn croesawu galwadau'n Gymraeg.

We welcome calls in Welsh.